NEOTIGASON 25 MG

国家: 以色列

语言: 英文

来源: Ministry of Health

现在购买

资料单张 资料单张 (PIL)
07-07-2020
产品特点 产品特点 (SPC)
19-03-2020
公众评估报告 公众评估报告 (PAR)
17-08-2016

有效成分:

ACITRETIN

可用日期:

ABIC MARKETING LTD, ISRAEL

ATC代码:

D05BB02

药物剂型:

CAPSULES

组成:

ACITRETIN 25 MG

给药途径:

PER OS

处方类型:

Required

厂商:

ACTAVIS GROUP PTC EHF, ICELAND

治疗组:

ACITRETIN

治疗领域:

ACITRETIN

疗效迹象:

Severe disorders of keratinization such as erythrodermic psoriasis local or generalized pustular psoriasis congenital ichthyosis pityriasis rubra pilaris darier's disease.

授权日期:

2017-01-31

资料单张

                                [לוגו מדינת ישראל] [http://www.gov.il/]
[http://www.gov.il/] [לוגו משרד הבריאות] [לוגו משרד
הבריאות] [*5400]
[http://www.health.gov.il/PniyotHazibur/Pages/CallCenter.aspx]
[http://www.health.gov.il/PniyotHazibur/Pages/CallCenter.aspx]
הציבור הרחב עסקים ומוסדות עובדים
בבריאות חפש מידע
תפריט	*
[סגירה]
סגור	*
דף הבית [http://www.health.gov.il/]	*
אודות	*
אודות המשרד
[http://www.health.gov.il/About/Pages/about_us.aspx]	*
תוכנית עבודה
[http://www.health.gov.il/About/Pages/Agenda.aspx]	*
תקציב המשרד
[http://www.health.gov.il/About/Pages/budget.aspx]	*
תרשים מבנה ארגוני
[http://www.health.gov.il/About/Pages/OrganizationalStructureDiagram.aspx]	*
בעלי תפקידים
[http://www.health.gov.il/About/Phonebook/Pages/PhoneBook.aspx]	*
יחידות המשרד
[http://www.health.gov.il/UnitsOffice/Pages/UnitsList.aspx]	*
לשכות הבריאות
[http://www.health.gov.il/About/Phonebook/Pages/PhoneBook.aspx?tab=3]	*
אמנת שירות
[http://www.health.gov.il/About/sla/Pages/default.aspx]	*
אותות ופרסים
[http://www.health.gov.il/About/Awards/Pages/mifal.aspx]	*
פרוייקטים תשתיתיים
[http://www.health.gov.il/About/projects/shared_medical_info/Pages/default.aspx]	*
דרושים
[http://www.health.gov.il/About/Careers/Pages/default.aspx]	*
מנכ"לי משרד הבריאות לדורותיהם
[http://www.health.gov.il/About/Pages/GeneralManegerHistory.aspx]	*
יחידות המשרד	*
יחידות המשרד
[http://www.health.gov.il/UnitsOffice/Pages/UnitsList.aspx]	*
לשכות הבריאות
[http://www.health.gov.il/UnitsOffice/LB/Pages/default.aspx]	*
וועדות ומועצות
[http://www.health.gov.il/Services/Committee/Pages/CommitteeList.aspx]	*
נושאים	*
בריאות הנפש
[http://www.health.gov.il/Subjects/mental_health/Pages/default.aspx]	*
בריאות הסביבה
[http://www.health.gov.il/Subjects/Environmental_Health/
                                
                                阅读完整的文件
                                
                            

产品特点

                                SUMMARY OF PRODUCT CHARACTERISTICS
▼THIS MEDICINAL PRODUCT IS SUBJECT TO ADDITIONAL MONITORING. THIS
WILL ALLOW QUICK
IDENTIFICATION OF NEW SAFETY INFORMATION. HEALTHCARE PROFESSIONALS ARE
ASKED TO
REPORT ANY SUSPECTED ADVERSE REACTIONS. SEE SECTION “UNDESIRABLE
EFFECTS” FOR HOW TO
REPORT ADVERSE REACTIONS.
NEOTIGASON 10MG AND 25MG CAPSULES
*************************************************************************************
1
NAME OF THE MEDICINAL PRODUCT
Neotigason 10mg Capsules
Neotigason25mg Capsules
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
10 mg Capsules:
Each capsule, contains Acitretin 10 mg
25 mg Capsules:
Each capsule, contains Acitretin 25 mg
Excipients with known affect: Glucose (see section _4.3
Contraindications_).
This medicine contains less than 1 mmol sodium (23 mg) per capsule,
that is to say
essentially ‘sodium-free’.
For a full list of excipients, see section _6.1 List of excipients_.
3
PHARMACEUTICAL FORM
Capsules for oral administration
10 mg Capsules:
Hard gelatin capsules with white body and brown cap with “10”
printed in black on the
body, containing 10 mg acitretin.
25mg Capsules:
Hard gelatin capsules with yellow body and brown cap with “25”
printed in black on the
body, containing 25 mg acitretin.
Neotigason Capsules 10mg, 25mg, SPC, 02-2020, HH, Notification
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Severe disorders of keratinization such as erythrodermic psoriasis
local or generalized or
pustular psoriasis congenital ichthyosis pityriasis rubra pilaris
darier's disease.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Neotigason should only be prescribed by physicians who are experienced
in the use of
systemic retinoids and understand the risk of teratogenicity
associated with acitretin
therapy (see Section 4.6).
The capsules should be taken once daily with meals or with milk.
There is a wide variation in the absorption and rate of metabolism of
Neotigason. This
necessitates individual adjustment of dosage. For this reason the
following dosage
recommendations can
                                
                                阅读完整的文件
                                
                            

其他语言的文件

资料单张 资料单张 阿拉伯文 07-07-2020
资料单张 资料单张 希伯来文 07-07-2020

搜索与此产品相关的警报